Cargando…
Clinical impact of chemotherapy to improve tumor microenvironment of pancreatic cancer
A perioperative multimodal strategy including combination chemotherapy and radiotherapy, in addition to surgical resection, has been acknowledged to improve patient prognosis. However chemotherapy has not been actively applied as an immunomodulating modality because of concerns about various immunos...
Autores principales: | Tsuchikawa, Takahiro, Takeuchi, Shintaro, Nakamura, Toru, Shichinohe, Toshiaki, Hirano, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108980/ https://www.ncbi.nlm.nih.gov/pubmed/27895816 http://dx.doi.org/10.4251/wjgo.v8.i11.786 |
Ejemplares similares
-
Potential risk of residual cancer cells in the surgical treatment of initially unresectable pancreatic carcinoma after chemoradiotherapy
por: Takano, Hironobu, et al.
Publicado: (2015) -
Stromal Palladin Expression Is an Independent Prognostic Factor in Pancreatic Ductal Adenocarcinoma
por: Sato, Daisuke, et al.
Publicado: (2016) -
Inhibition of Eph receptor A4 by 2,5-dimethylpyrrolyl benzoic acid suppresses human pancreatic cancer growing orthotopically in nude mice
por: Takano, Hironobu, et al.
Publicado: (2015) -
Surgery for recurrent biliary carcinoma: results for 27 recurrent cases
por: Noji, Takehiro, et al.
Publicado: (2015) -
Long-term survival after repetitive lymphadenectomy for nodal recurrence of pancreatic neuroendocrine neoplasms: a report of two cases
por: Hane, Yuma, et al.
Publicado: (2021)